Trial Profile
A phase 2 study of VELCADE [bortezomib] in subjects with relapsed or refractory mantle cell lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Mar 2008
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- Acronyms PINNACLE
- 25 Sep 2005 New trial record.